(Q37766119)

22 August 2017

1 reference

title

New antituberculous drugs in development (English)

1 reference

22 August 2017

Umesh G Lalloo

1

1 reference

22 August 2017

Anish Ambaram

series ordinal

2

1 reference

22 August 2017

publication date

1 August 2010

1 reference

22 August 2017

published in

Current HIV/AIDS reports

1 reference

22 August 2017

volume

7

1 reference

22 August 2017

issue

3

1 reference

22 August 2017

page(s)

143-151

1 reference

Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0054-4

Effectiveness of ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium, and rifampin against M. tuberculosis in cultured human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0054-4

Long-term tolerance and effectiveness of moxifloxacin therapy for tuberculosis: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0054-4

Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0054-4

Effect of rifampicin and isoniazid on vitamin D metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-010-0054-4

Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06.

21 January 2018

1 reference

12 December 2020

A single dose of vitamin D enhances immunity to mycobacteria

1 reference

12 December 2020

New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery.

1 reference

12 December 2020

Calcium metabolism during rifampicin and isoniazid therapy for tuberculosis

1 reference

12 December 2020

In vitro and in vivo activities of new rifamycin derivatives against mycobacterial infections

1 reference

12 December 2020

Safety and bactericidal activity of rifalazil in patients with pulmonary tuberculosis

1 reference

12 December 2020

Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis

1 reference

12 December 2020

HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality

1 reference

12 December 2020

In search of new cures for tuberculosis

1 reference

12 December 2020

Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study

1 reference

12 December 2020

Fluoroquinolones as chemotherapeutics against mycobacterial infections

1 reference

12 December 2020

Effective treatment of acute and chronic murine tuberculosis with liposome-encapsulated clofazimine

1 reference

12 December 2020

Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes

1 reference

12 December 2020

Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications

1 reference

12 December 2020

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

1 reference

12 December 2020

Chemotherapeutic activity of clofazimine and its analogues against Mycobacterium tuberculosis. In vitro, intracellular, and in vivo studies

1 reference

12 December 2020

The complex of DNA gyrase and quinolone drugs with DNA forms a barrier to transcription by RNA polymerase.

1 reference

12 December 2020

A possible link between vitamin D deficiency and impaired host defence to Mycobacterium tuberculosis

1 reference

12 December 2020

Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis

1 reference

12 December 2020

Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial

1 reference

12 December 2020

Synthesis and evaluation of SQ109 analogues as potential anti-tuberculosis candidates

1 reference

12 December 2020

Pharmacokinetics of rifampin in children. II. Oral bioavailability

1 reference

12 December 2020

Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis

1 reference

12 December 2020

Lack of activity of orally administered clofazimine against intracellular Mycobacterium tuberculosis in whole-blood culture

1 reference

12 December 2020

Inhibition by 1,25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages

1 reference

12 December 2020

Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene

1 reference

12 December 2020

Fluoroquinolones, tuberculosis, and resistance

1 reference

12 December 2020

In-vitro activity of six fluorinated quinolones against Mycobacterium tuberculosis

1 reference

12 December 2020

Recent advances in the medical and surgical treatment of multi-drug resistant tuberculosis

1 reference

12 December 2020

Sterilizing activities of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis

1 reference

12 December 2020

Advances in the treatment of tuberculosis

1 reference

12 December 2020

Drug therapy of experimental tuberculosis (TB): improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs

1 reference

12 December 2020

Early bactericidal activity of amoxicillin in combination with clavulanic acid in patients with sputum smear-positive pulmonary tuberculosis

1 reference

12 December 2020

Vitamin D earns more than a passing grade

1 reference

12 December 2020

Current status of some antituberculosis drugs and the development of new antituberculous agents with special reference to their in vitro and in vivo antimicrobial activities

1 reference

12 December 2020

New anti-tuberculosis drugs with novel mechanisms of action.

1 reference

12 December 2020

In-vitro susceptibility of mycobacteria to ciprofloxacin.

1 reference

12 December 2020

Prochlorperazine (compazine) as an aid in the treatment of pulmonary tuberculosis

1 reference

12 December 2020

Rates and mechanisms of resistance development in Mycobacterium tuberculosis to a novel diarylquinoline ATP synthase inhibitor

1 reference

12 December 2020

Fluoroquinolones for treating tuberculosis

1 reference

12 December 2020

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

1 reference

12 December 2020

Linezolid for the treatment of multidrug-resistant tuberculosis

1 reference

12 December 2020

Acquired rifamycin resistance in persons with advanced HIV disease being treated for active tuberculosis with intermittent rifamycin-based regimens

1 reference

12 December 2020

[Treatment of pulmonary tuberculosis with PAS infusions associated with INH and streptomycin.]

1 reference

12 December 2020

Linezolid for the treatment of patients with [corrected] mycobacterial infections [corrected] a systematic review

1 reference

12 December 2020

4-Quinolone interactions with gyrase subunit B inhibitors

1 reference

12 December 2020

Imipenem for treatment of tuberculosis in mice and humans

1 reference

12 December 2020

The mechanism of action of PA-824: Novel insights from transcriptional profiling

1 reference

12 December 2020

Activities of linezolid against rapidly growing mycobacteria

1 reference

12 December 2020

Whither short-course chemotherapy?

1 reference

12 December 2020

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis

1 reference

12 December 2020

A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis

1 reference

12 December 2020

Toward an optimized therapy for tuberculosis? Drugs in clinical trials and in preclinical development

1 reference

12 December 2020

Long term study of the effect of rifampicin and isoniazid on vitamin D metabolism

1 reference

12 December 2020

Inhaled drug delivery for tuberculosis therapy

1 reference

12 December 2020

Moxifloxacin-containing Regimen Greatly Reduces Time to Culture Conversion in Murine Tuberculosis

1 reference

12 December 2020

Activity of amoxicillin/clavulanate in patients with tuberculosis

1 reference

12 December 2020

Managing tuberculosis and HIV in sub-Sahara Africa

1 reference

12 December 2020

Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol

1 reference

12 December 2020

New drugs for tuberculosis: current status and future prospects

1 reference

12 December 2020

In vitro activities of six fluoroquinolones against 250 clinical isolates of Mycobacterium tuberculosis susceptible or resistant to first-line antituberculosis drugs

1 reference

12 December 2020

Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors

1 reference

12 December 2020

10.1007/S11904-010-0054-4

Identifiers

DOI

1 reference

22 August 2017

1 reference